市場調查報告書

夜間視覺障礙(NVD)- 市場洞察,流行病學,預測 2028年

Night Vision Disturbances Market Insights, Epidemiology and Market Forecast - 2028

出版商 DelveInsight Business Research LLP 商品編碼 918180
出版日期 內容資訊 英文 45 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
夜間視覺障礙(NVD)- 市場洞察,流行病學,預測 2028年 Night Vision Disturbances Market Insights, Epidemiology and Market Forecast - 2028
出版日期: 2019年12月01日內容資訊: 英文 45 Pages
簡介

主要7個國家(美國、英國、德國、法國、義大利、西班牙、日本)的夜間視覺障礙(NVD)的2017年的罹患數估算為339萬2,937人,同年的美國的市場規模估算為7億6,100萬美元。

本報告提供美國的夜間視覺障礙(NVD)市場相關調查,疾病概要,新藥的簡介,美國市場趨勢,流行病學的預測,市場規模,各市場區隔的罹患數的變化與預測,未滿足需求,市場成長要素及障礙等資訊總括性彙整。

目錄

第1章 重要的洞察

第2章 疾病背景和概要

  • 簡介
  • 夜間視覺障礙(NVD)的種類
  • 原因和風險因素
  • 病因
  • 症狀
  • 診斷

第3章 流行病學和患者數

  • 主要調查結果
  • 假設和根據
  • 美國的夜間視覺障礙(NVD)的總罹患數
  • 美國的夜間視覺障礙(NVD)的罹患數:各手術類型
  • 美國的夜間視覺障礙(NVD)的發病率

第4章 治療

第5章 未滿足需求

第6章 新藥

  • Nyxol:Ocuphire Pharma
    • 產品說明
    • 產品開發活動
    • 臨床開發
  • 安全性和有效性
  • 產品簡介

第7章 美國的夜間視覺障礙(NVD)市場

  • 市場預測
  • 主要調查結果
  • 整體市場規模
  • 市場規模:各治療藥物

第8章 市場障礙

第9章 市場成長要素

第10章 附錄

  • 調查手法

第11章 DelveInsight的服務內容

第12章 免責聲明

第13章 關於DelveInsight

目錄
Product Code: DIMI0793

DelveInsight's 'Night Vision Disturbances (NVD)- Market Insights, Epidemiology and Market Forecast-2028' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of NVDs in the United States.

The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Night Vision Disturbances (NVD) from 2017 to 2028 in the United States. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

Geography Covered

  • The United States

Study Period: 2017-2028

Night Vision Disturbances (NVD) - Disease Understanding and Treatment Algorithm

Night Vision Disturbances (NVD) means difficulty (i.e. poor or inability) to see in dark conditions and it is harder and takes longer time to adjust and visualize when there is a change from well-lighted conditions to darkness. Bright circles that surround the light source are known as hallos whereas difficulty in seeing due to a direct or reflected bright light is known as glare.

The DelveInsight Night Vision Disturbances (NVD) market report gives the thorough understanding of the Night Vision Disturbances by including details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends. It also provides treatment algorithms and treatment guidelines for Night Vision Disturbances in the US, Europe and Japan.

Night Vision Disturbances Epidemiology

The Night Vision Disturbances (NVD) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Incident Cases of NVD in the United States, Incident cases of NVD by Type of Surgeries, Incidence of NVD Manifestations) scenario of Night Vision Disturbances (NVD)in the United States from 2017-2028.

According to DelveInsight, the total number of Incident cases of Night Vision Disturbances (NVD) in 7 MM was found to be 3,392,937 in the year 2017. 

Night Vision Disturbances Drug Chapters

This segment of the Night Vision Disturbances report encloses the detailed analysis of late stage (Phase-II) drug, Nyxol. Nyxol (Lynx-1) is a novel eye drop treatment for multiple front-of-the-eye disorders, including night vision disturbances (NVD). This segment also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Night Vision Disturbances Market Outlook

The Night Vision Disturbances market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a through detail of market trend of Nyxol by evaluating its impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the market of Night Vision Disturbances in the US was found to be USD 761 Million in 2017, and is expected to increase during the course of the study period (2017-2028).

Night Vision Disturbances Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2017-2028. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Night Vision Disturbances Report Insights

  • Patient Population
  • Therapeutic Approaches
  • Pipeline Analysis
  • Market Size and Trends
  • Market Opportunities
  • Impact of upcoming Therapies

Night Vision Disturbances Report Key Strengths

  • 10 Years Forecast
  • The United States Coverage
  • Epidemiology Segmentation
  • Key Cross Competition
  • Market Size by Therapies
  • Drugs Uptake

Night Vision Disturbances Report Assessment

  • Pipeline Product Profiles
  • Key Products and Key Players
  • Market Drivers and Barriers

Key Benefits

  • This DelveInsight report will help to develop Business Strategies by understanding the trends shaping and driving Night Vision Disturbances market
  • Organize sales and marketing efforts by identifying the best opportunities for Night Vision Disturbances market
  • To understand the future market competition in the Night Vision Disturbances market.

Note: We understand the needs of the rapidly changing market and DelveInsight's is helping the client by providing the most up to date Report. It usually takes 24 Hours to deliver this kind of Report.

Table of Contents

1. Key Insights

2. Disease Background and Overview

  • 2.1. Introduction
  • 2.2. Types of NVD
  • 2.3. Causes and Risk Factors
  • 2.4. Etiology of NVD
  • 2.5. Symptoms
  • 2.6. Diagnosis

3. Epidemiology and Patient Population

  • 3.1. Key Findings
  • 3.2. Assumptions and Rationale
  • 3.3. Total Incident Cases of NVD in the United States
  • 3.4. Incident cases of NVD by Type of Surgeries in the United States
  • 3.5. Incidence of NVD Manifestations in the United States

4. Treatment

5. Unmet needs

6. Emerging Drugs

  • 6.1. Nyxol: Ocuphire Pharma
    • 6.1.1. Product Description
    • 6.1.2. Product Development Activities
    • 6.1.3. Clinical development
      • 6.1.3.1. Clinical Trials Information
  • 6.2. Safety and Efficacy
  • 6.3. Product Profile

7. Night Vision Disturbances (NVD): The United States Market

  • 7.1. Market Outlook
  • 7.2. Key Findings
  • 7.3. Market Size of NVD in the United States
  • 7.4. Market Size of NVD by Therapies

8. Market Barriers

9. Market Drivers

10. Appendix

  • 10.1. Report Methodology

11. DelveInsight Capabilities

12. Disclaimer

13. About DelveInsight

List of Tables

  • Table 1: List of different diagnostic tests for NVD
  • Table 2: Total Incident Cases of NVD in the United States (2017-2028)
  • Table 3: Incident cases of NVD by Type of Surgeries in the United States (2017-2028)
  • Table 4: Incidence of NVD Manifestations in the United States (2017-2028)
  • Table 5: Total Market Size of NVD in the United Sates in USD Million (2017-2028)
  • Table 6: Total Market Size of NVD by Therapies in the United States in USD Million (2017-2028)

List of Figures

  • Figure 1: Anatomy of a Human Eye
  • Figure 2: Depiction of Halos and Glare
  • Figure 3: Risk factors associated with NVD:
  • Figure 4: Symptoms associated with NVD
  • Figure 5: Total Incident Cases of NVD in the United States (2017-2028)
  • Figure 6: Incident cases of NVD by Type of Surgeries in the United States (2017-2028)
  • Figure 7: Incidence of NVD Manifestations in the United States (2017-2028)
  • Figure 8: Unmet needs of NVD
  • Figure 9: Market drivers of NVD
  • Figure 10: Market barriers of NVD
Back to Top